Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:793-798
Published online before print March 21, 2002, doi: 10.1161/01.ATV.0000016046.94521.68
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/5/793    most recent
01.ATV.0000016046.94521.68v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alber, D. G.
Right arrow Articles by Powell, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alber, D. G.
Right arrow Articles by Powell, K. L.
Related Collections
Right arrow Animal models of human disease
Right arrow Risk Factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:793.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Enhanced Atherogenesis Is Not an Obligatory Response to Systemic Herpesvirus Infection in the ApoE-Deficient Mouse

Comparison of Murine {gamma}-Herpesvirus-68 and Herpes Simplex Virus-1

Dagmar G. Alber; Patrick Vallance*; Kenneth L. Powell*

From the Wolfson Institute for Biomedical Research (D.G.A., K.L.P.) and the Centre for Clinical Pharmacology and Therapeutics (D.G.A., P.V.), Rayne Institute (BHF Laboratories), University College London, London, UK.

Correspondence to Dr Dagmar G. Alber, Wolfson Institute for Biomedical Research, University College London, Cruciform Building, Gower Street, London WC1E 6BT, UK. E-mail d.alber{at}ucl.ac.uk

Viral and bacterial infectious agents have been implicated in the etiology of atherosclerosis. We have previously shown that a {gamma}-herpesvirus can accelerate atherosclerosis in the apolipoprotein E–deficient (apoE-/-) mouse. To address whether a virally induced systemic immune response is sufficient to trigger enhanced atheroma formation, we infected apoE-/- mice with murine {gamma}-herpesvirus-68 (MHV-68) or herpes simplex virus-1 (HSV-1). In this study, we show that both viruses were able to induce a cell-mediated and humoral immune response in the apoE-/- mouse, which was sustained over a period of 24 weeks. Although intranasal or intraperitoneal infection with MHV-68 induced similar levels of virus-specific IgG1 and IgG2a antibodies in the serum of apoE-/- mice, those infected with HSV-1 showed higher anti–HSV-1 IgG2a compared with IgG1 antibody levels. In addition, viral message was not detected in the aortas of HSV-1–infected animals, whereas we have shown previously that MHV-68 mRNA can be detected in the aortas of infected mice as early as 5 days after infection. Compared with control mice, apoE-/- mice infected with MHV-68 showed accelerated atherosclerosis, whereas mice infected with HSV-1 did not. These data indicate that a systemic immune response to any particular infectious agent is insufficient to induce enhanced atherosclerosis in the apoE-/- mouse and point to specific infections or immune mechanisms that might be essential for virally enhanced atherogenesis.


Key Words: atherosclerosis • infection • herpesvirus • animal models




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Krebs, E. Scandella, B. Bolinger, D. Engeler, S. Miller, and B. Ludewig
Chronic Immune Reactivity Against Persisting Microbial Antigen in the Vasculature Exacerbates Atherosclerotic Lesion Formation
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2206 - 2213.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Charakida, A. E. Donald, H. Green, C. Storry, M. Clapson, M. Caslake, D. T. Dunn, J. P. Halcox, D. M. Gibb, N. J. Klein, et al.
Early Structural and Functional Changes of the Vasculature in HIV-Infected Children: Impact of Disease and Antiretroviral Therapy
Circulation, July 5, 2005; 112(1): 103 - 109.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Charakida, A. E. Donald, M. Terese, S. Leary, J. P. Halcox, A. Ness, G. D. Smith, J. Golding, P. Friberg, N. J. Klein, et al.
Endothelial Dysfunction in Childhood Infection
Circulation, April 5, 2005; 111(13): 1660 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. D. de Kruif, E. C.M. van Gorp, T. T. Keller, J. M. Ossewaarde, and H. ten Cate
Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research
Cardiovasc Res, February 1, 2005; 65(2): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. Ludewig, P. Krebs, and E. Scandella
Immunopathogenesis of atherosclerosis
J. Leukoc. Biol., August 1, 2004; 76(2): 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Grahame-Clarke, N. N. Chan, D. Andrew, G. L. Ridgway, D. J. Betteridge, V. Emery, H. M. Colhoun, and P. Vallance
Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function
Circulation, August 12, 2003; 108(6): 678 - 683.
[Abstract] [Full Text] [PDF]